4-hydroxyatomoxetine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2016
02420022016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Atomoxetine is a selective norepinephrine reuptake inhibitor indicated for the treatment of attention-deficit/hyperactivity… (More)
Is this relevant?
2013
2013
Atomoxetine (ATX) is a non-stimulant drug approved for the treatment of children and adolescents with attention deficit… (More)
  • figure 2
  • figure 1
  • figure 5
  • figure 3
  • figure 4
Is this relevant?
2012
2012
A procedure based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) is described for determination of atomoxetine (ATX… (More)
  • figure 2
  • table 2
  • table 3
Is this relevant?
2004
2004
In the studies reported here, the ability of atomoxetine hydrochloride (Strattera) to inhibit or induce the metabolic… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
  • table 5
Is this relevant?
2003
2003
The role of the polymorphic cytochrome p450 2D6 (CYP2D6) in the pharmacokinetics of atomoxetine hydrochloride [(-)-N-methyl-gamma… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2003
2003
OBJECTIVE Atomoxetine is indicated for the treatment of attention deficit hyperactivity disorder in children, adolescents, and… (More)
Is this relevant?
2003
2003
These studies were designed to characterize the disposition and metabolism of atomoxetine hydrochloride [(-)-N-methyl-gamma-(2… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2003
2003
BACKGROUND AND OBJECTIVES Atomoxetine is a treatment for attention-deficit/hyperactivity disorder and is primarily eliminated via… (More)
Is this relevant?
2002
2002
Studies were performed to determine the human enzymes responsible for the biotransformation of atomoxetine to its major… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2002
2002
The purpose of this study was to characterize the effect of potent CYP2D6 inhibition byparoxetine on atomoxetine disposition in… (More)
Is this relevant?